News Announcement

Vivanza Biosciences: Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations 2015

Pursuant to Regulation 32 of the SEBI(LODR) Regulation 2015 Read with SEBI circular dated 24th December 2019 regarding the submission of the statement of deviation or variation from the proceeds of public issue/rights issue/preferential issue qualified institutional placement etc. we hereby confirm that the company has not raised any further funds by means of Public Issue rights issue or preferential issue etc. hence the statement of deviation and variation is not applicable to the company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.